|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-04
|
$701,778
|
$14,036
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Multiplexed In Solution Protein Array (MISPA) for identifying novel protein interactions in cancer and for early detection of immune responses in pathogen-induced cancers
|
5R21CA196442-03
|
$201,623
|
$201,623
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
ENHANCING T CELL THERAPY OF CANCER
|
5P01CA094237-15
|
$1,932,287
|
$463,749
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$2,367
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$2,378
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$2,445
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$5,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$65,062
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization
|
5R01CA200651-02
|
$383,385
|
$383,385
|
WEI, WENYI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of a companion diagnostic to predict response to cetuximab in patients with head and neck squamous cell carcinoma
|
1R43CA224512-01
|
$299,340
|
$299,340
|
BERTENSHAW, GREG
|
BIOMARKER STRATEGIES, LLC
|
|
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
|
5U01CA187508-03
|
$590,572
|
$590,572
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
3U24CA180918-05S1
|
$254,713
|
$84,055
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
5U24CA180918-05
|
$668,865
|
$220,725
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-04S1
|
$76,498
|
$1,912
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-04
|
$1,188,450
|
$29,711
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Prevention of Depression in Head and Neck Cancer
|
5R21CA197023-02
|
$228,375
|
$228,375
|
IRWIN, SCOTT
|
CEDARS-SINAI MEDICAL CENTER
|
|
Quantitative Radiomics System Decoding the Tumor Phenotype
|
5U24CA194354-03
|
$778,713
|
$389,357
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
|
5R01CA196932-03
|
$387,027
|
$193,514
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-04
|
$1,302,199
|
$32,555
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
$115,928
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S1
|
$112,500
|
$1,125
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-04
|
$357,058
|
$17,853
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-38S1
|
$100,606
|
$1,006
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-38S2
|
$124,999
|
$1,250
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-38S3
|
$45,000
|
$450
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-38S4
|
$47,801
|
$478
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-38
|
$3,189,824
|
$31,898
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy
|
5P01CA190193-03
|
$1,372,998
|
$178,490
|
SWARTZ, HAROLD
|
DARTMOUTH COLLEGE
|
|
ECOG-ACRIN Operations Center
|
3U10CA180820-04S1
|
$394,013
|
$9,850
|
COMIS, ROBERT
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
ECOG-ACRIN Operations Center
|
5U10CA180820-04
|
$11,276,830
|
$281,921
|
O'DWYER, PETER
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$75,732
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$1,800
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$3,062
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Planning a Regional Center of Research Excellence in Non-communicable Diseases in India
|
5P20CA210298-02
|
$242,714
|
$121,357
|
GOODMAN, MICHAEL
|
EMORY UNIVERSITY
|
|
Role of MAST1 kinase in cisplatin resistant cancers
|
1R01CA207768-01A1
|
$356,850
|
$117,761
|
KANG, SUMIN
|
EMORY UNIVERSITY
|
|
Transcription-dependent and -independent signaling of RSK2 in cancer metastasis
|
5R01CA175316-04
|
$323,700
|
$106,821
|
KANG, SUMIN
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$54,280
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Translational Physician-Scientist Training Program in Oncology
|
5T32CA160040-05
|
$242,661
|
$60,665
|
SHIN, DONG
|
EMORY UNIVERSITY
|
|
miR-21 signaling in tumor response to radiation treatment
|
5R01CA186129-04
|
$323,700
|
$106,821
|
WANG, YA
|
EMORY UNIVERSITY
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-04
|
$637,150
|
$31,858
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
FFPE Validation of a Survival Gene Signature in HPV-Negative Oral Cavity Cancer
|
5R01CA177736-03
|
$612,024
|
$612,024
|
CHEN, CHU
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
CDK2 and Cancer: Mechanisms and Opportunities
|
5R01CA193808-02
|
$409,815
|
$204,908
|
CLURMAN, BRUCE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S1
|
$249,999
|
$5,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S2
|
$125,000
|
$2,500
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S3
|
$58,085
|
$1,162
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S4
|
$70,220
|
$1,404
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
$191,186
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer
|
1R01CA215647-01A1
|
$415,275
|
$415,275
|
MENDEZ, EDUARDO
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Head and Neck for this search: $63,647,517
|